Evidence map›Paper›PMID 32438526›Full record

ArticleThe Laryngoscope2021

Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.

Jennifer Kersigo, Lintao Gu, Linjing Xu, Ning Pan, Sarath Vijayakuma, Timothy Jones, Seiji B Shibata, Bernd Fritzsch, Marlan R Hansen

Open access · greenAbstract read
In one paragraph

Article in The Laryngoscope, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Evolution and development of extraocular motor neurons, nerves and muscles in vertebrates.Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft · 2024
    Review
  5. Early Steps towards Hearing: Placodes and Sensory Development.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Sustained Loss ofFrontiers in neurology · 2021
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Jennifer KersigoDepartment of Biology, University of Lowa, Lowa City, Lowa, U.S.A.
Lintao GuDepartment of Otolaryngology, University of Lowa, Lowa City, Lowa, U.S.A.
Linjing XuDepartment of Otolaryngology, University of Lowa, Lowa City, Lowa, U.S.A.
Ning PanDepartment of Biology, University of Lowa, Lowa City, Lowa, U.S.A.
Sarath VijayakumaDepartment of Otolaryngology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.
Timothy JonesDepartment of Otolaryngology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.
Seiji B ShibataDepartment of Otolaryngology, University of Lowa, Lowa City, Lowa, U.S.A.
Bernd FritzschDepartment of Biology, University of Lowa, Lowa City, Lowa, U.S.A.ORCID 0000-0002-4882-8398
Marlan R HansenDepartment of Otolaryngology, University of Lowa, Lowa City, Lowa, U.S.A.ORCID 0000-0002-6884-4897
Showa University · JPAffiliated Hospital of Shandong University of Traditional Chinese Medicine · CNUniversity of Nebraska–Lincoln · US

Funding

The University of Iowa Clinical and Translational Science AwardUL1TR002537 · NCATS · UNIVERSITY OF IOWA · PI HANSEN, MARLAN R, WINOKUR, PATRICIA · 2018 to 2022
$20.0M
Structural Analyses CoreP01AG051443 · NIA · UNIVERSITY OF NEVADA RENO · PI YAMOAH, EBENEZER N · 2016 to 2025
$15.5M
Mechanisms of Growth Factor Responsiveness in the Aging Auditory SystemR01AG060504 · NIA · UNIVERSITY OF NEVADA RENO · PI FRITZSCH, BERND, YAMOAH, EBENEZER N · 2018 to 2022
$2.5M
Regulation of hair cell functionsR01DC015252 · NIDCD · UNIVERSITY OF NEVADA RENO · PI YAMOAH, EBENEZER N · 2017 to 2021
$2.1M
FUNCTIONAL PROPERTIES OF CA PUMPS IN HAIR CELLR01DC004215 · NIDCD · UNIVERSITY OF CINCINNATI · PI YAMOAH, EBENEZER N. · 1999 to 2003
$1.0M
NCATS NIH HHS UL1 TR002537NIA NIH HHS P01 AG051443NIA NIH HHS R01 AG060504NIDCD NIH HHS R01 DC004215NIDCD NIH HHS R01 DC015252
6 · The paper itself

Abstract

objectivesThe objective was to explore the effect of the proneuronal transcription factor neurogenic differentiation 1 (Neurod1, ND1) on Schwann cells (SC) and schwannoma cell proliferation.

methodsUsing a variety of transgenic mouse lines, we investigated how expression of Neurod1 effects medulloblastoma (MB) growth, schwannoma tumor progression, vestibular function, and SC cell proliferation. Primary human vestibular schwannoma (VS) cell cultures were transduced with adenoviral vectors expressing Neurod1. Cell proliferation was assessed by 5-ethynyl-2'-deoxyuridine (EdU) uptake. STUDY

designBasic science investigation.

resultsExpression of Neurod1 reduced the growth of slow-growing but not fast-growing MB models. Gene transfer of Neurod1 in human schwannoma cultures significantly reduced cell proliferation in dose-dependent way. Deletion of the neurofibromatosis type 2 (Nf2) tumor-suppressor gene via Cre expression in SCs led to increased intraganglionic SC proliferation and mildly reduced vestibular sensory-evoked potentials (VsEP) responses compared to age-matched wild-type littermates. The effect of Neurod1-induced expression on intraganglionic SC proliferation in animals lacking Nf2 was mild and highly variable. Sciatic nerve axotomy significantly increased SC proliferation in wild-type and Nf2-null animals, and expression of Neurod1 reduced the proliferative capacity of both wild-type and Nf2-null SCs following nerve injury.

conclusionExpression of Neurod1 reduces slow-growing MB progression and reduces human SC proliferation in primary VS cultures. In a genetic mouse model of schwannomas, we find some effects of Neurod1 expression; however, the high variability indicates that more tightly regulated Neurod1 expression levels that mimic our in vitro data are needed to fully validate Neurod1 effects on schwannoma progression. LEVEL OF EVIDENCE: NA Laryngoscope, 131:E259-E270, 2021.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCell ProliferationHumansMedulloblastomaMiceMice, TransgenicNeuroma, AcousticSchwann CellsTumor Cells, CulturedBasic Helix-Loop-Helix ProteinsNEUROD1 protein, humanNeurod1 protein, mouseVestibular schwannoma, Schwann cell, Neurod1, medulloblastoma, tumor suppression

Identifiers

PMID32438526
PMCPMC7772964
OpenAlexW3027247236

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.